Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $803.36 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $231.57 | 2 | $0 (2022) |
| Ardelyx, Inc. | $124.99 | 1 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2024) |
| Lucid Diagnostics Inc. | $118.61 | 1 | $0 (2022) |
| AbbVie Inc. | $103.92 | 1 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $99.28 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.99 | 1 | Phathom Pharmaceuticals, Inc. ($124.99) |
| 2023 | $124.99 | 1 | Ardelyx, Inc. ($124.99) |
| 2022 | $250.18 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($131.57) |
| 2021 | $103.92 | 1 | AbbVie Inc. ($103.92) |
| 2018 | $100.00 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($100.00) |
| 2017 | $99.28 | 1 | Valeant Pharmaceuticals North America LLC ($99.28) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/11/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2022 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $118.61 | General |
| 08/24/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $131.57 | General |
| Category: Gastroenterology | ||||||
| 09/29/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $103.92 | General |
| Category: VIROLOGY | ||||||
| 06/12/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.28 | General |
| Category: GASTROENTEROLOGY | ||||||
About Dr. Gauri Kumar, DDS
Dr. Gauri Kumar, DDS is a General Practice healthcare provider based in Santa Ana, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841387651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gauri Kumar, DDS has received a total of $803.36 in payments from pharmaceutical and medical device companies, with $124.99 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($803.36).
Practice Information
- Specialty General Practice
- Location Santa Ana, CA
- Active Since 10/05/2006
- Last Updated 04/01/2008
- Taxonomy Code 1223G0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841387651
Products in Payments
- XIFAXAN (Drug) $330.85
- IBSRELA (Drug) $124.99
- VOQUEZNA (Drug) $124.99
- MAVYRET (Drug) $103.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Santa Ana
Dr. Joseph Kim, D.d.s, D.D.S
General Practice — Payments: $49,752
David Sanchez, Md, MD
General Practice — Payments: $15,716
Lucy Saenz, Md, MD
General Practice — Payments: $6,018
Linda Pearce, Dds, DDS
General Practice — Payments: $3,914
Mr. Viet Nghiem, Dds, DDS
General Practice — Payments: $3,039
Dr. Majid Kashani, D.d.s, D.D.S
General Practice — Payments: $2,664